Similar articles for PMID: 12018459

Year	Number of Results
1991	1
1992	1
1993	1
1994	1
1996	5
1997	1
1998	3
1999	3
2000	3
2001	5
2002	4
2003	2
2004	2
2005	10
2006	5
2007	3
2008	1
2009	4
2010	3
2011	4
2012	3
2013	3
2014	1
2015	6
2016	6
2017	7
2018	4
2019	2
2021	3
2024	0

1

Neutralizing antibodies mechanism of neutralization and protective activity against HIV-1.

Xiao Y, Dong X, Chen YH. Xiao Y, et al. Immunol Res. 2002;25(3):193-200. doi: 10.1385/IR:25:3:193. Immunol Res. 2002. PMID: 12018459 Review.

2

Epitope-vaccines: a new strategy to induce high levels of neutralizing antibodies against HIV-1.

Xiao Y, Liao M, Lu Y, Dierich MP, Chen YH. Xiao Y, et al. Immunobiology. 2000 Jan;201(3-4):323-31. doi: 10.1016/S0171-2985(00)80087-X. Immunobiology. 2000. PMID: 10776789

3

Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C-Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in the V1 Loop.

Patil S, Kumar R, Deshpande S, Samal S, Shrivastava T, Boliar S, Bansal M, Chaudhary NK, Srikrishnan AK, Murugavel KG, Solomon S, Simek M, Koff WC, Goyal R, Chakrabarti BK, Bhattacharya J. Patil S, et al. J Virol. 2016 Jan 13;90(7):3446-57. doi: 10.1128/JVI.03090-15. J Virol. 2016. PMID: 26763999 Free PMC article.

4

Role of neutralizing antibodies in protective immunity against HIV.

Srivastava IK, Ulmer JB, Barnett SW. Srivastava IK, et al. Hum Vaccin. 2005 Mar-Apr;1(2):45-60. doi: 10.4161/hv.1.2.1764. Epub 2005 Mar 17. Hum Vaccin. 2005. PMID: 17038830 Review.

5

Induction of high levels of antibodies recognizing the neutralizing epitope ELDKWA and the D- or K-position-mutated epitopes by candidate epitope vaccines against HIV-1.

Xiao Y, Dong X, Chen Y. Xiao Y, et al. Int Arch Allergy Immunol. 2000 Aug;122(4):287-92. doi: 10.1159/000024411. Int Arch Allergy Immunol. 2000. PMID: 10971120

6

Epitope-vaccine strategy against HIV-1: today and tomorrow.

Liu Z, Xiao Y, Chen YH. Liu Z, et al. Immunobiology. 2003;208(4):423-8. doi: 10.1078/0171-2985-00286. Immunobiology. 2003. PMID: 14748515 Review.

7

hu-PBL-SCID mice can be protected from HIV-1 infection by passive transfer of monoclonal antibody to the principal neutralizing determinant of envelope gp120.

Safrit JT, Fung MS, Andrews CA, Braun DG, Sun WN, Chang TW, Koup RA. Safrit JT, et al. AIDS. 1993 Jan;7(1):15-21. doi: 10.1097/00002030-199301000-00002. AIDS. 1993. PMID: 7680205

8

Broadly neutralizing antibodies against HIV-1: templates for a vaccine.

van Gils MJ, Sanders RW. van Gils MJ, et al. Virology. 2013 Jan 5;435(1):46-56. doi: 10.1016/j.virol.2012.10.004. Virology. 2013. PMID: 23217615 Free article. Review.

9

Polyvalent HIV-1 Env vaccine formulations delivered by the DNA priming plus protein boosting approach are effective in generating neutralizing antibodies against primary human immunodeficiency virus type 1 isolates from subtypes A, B, C, D and E.

Wang S, Pal R, Mascola JR, Chou TH, Mboudjeka I, Shen S, Liu Q, Whitney S, Keen T, Nair BC, Kalyanaraman VS, Markham P, Lu S. Wang S, et al. Virology. 2006 Jun 20;350(1):34-47. doi: 10.1016/j.virol.2006.02.032. Epub 2006 Apr 17. Virology. 2006. PMID: 16616287 Free article.

10

In vivo protection by broadly neutralizing HIV antibodies.

van Gils MJ, Sanders RW. van Gils MJ, et al. Trends Microbiol. 2014 Oct;22(10):550-1. doi: 10.1016/j.tim.2014.08.006. Epub 2014 Aug 26. Trends Microbiol. 2014. PMID: 25169020

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

94 results

Results by year